PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $1.65 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.65M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.34M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $5.24M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $5.48M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $1.65M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $4.34M 10-K · filed 2026-05-14 | |
| 2025-12-31 | $5.24M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $5.48M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $13.24M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $17.51M 10-K · filed 2025-05-09 | |
| 2024-12-31 | $15.61M 10-Q · filed 2026-02-05 | |
| 2024-09-30 | $15.70M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $14.21M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $17.66M 10-K · filed 2024-05-15 | |
| 2023-12-31 | $12.70M 10-Q · filed 2025-02-06 | |
| 2023-09-30 | $10.17M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $13.37M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $20.21M 10-K · filed 2023-05-05 | |
| 2022-12-31 | $20.29M 10-Q · filed 2024-02-08 | |
| 2022-09-30 | $10.96M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $20.05M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $14.24M 10-K · filed 2022-05-06 | |
| 2021-12-31 | $22.83M 10-Q · filed 2023-02-02 | |
| 2021-09-30 | $20.59M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $17.07M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $9.85M 10-K · filed 2021-05-07 | |
| 2020-12-31 | $3.99M 10-Q · filed 2022-02-03 | |
| 2020-09-30 | $5.03M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $5.77M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $6.21M 10-K · filed 2020-05-08 | |
| 2019-12-31 | $9.04M 10-Q · filed 2021-02-04 | |
| 2019-09-30 | $3.96M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $2.54M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $2.05M 10-K · filed 2019-05-13 | |
| 2018-12-31 | $2.48M 10-Q · filed 2020-02-06 | |
| 2018-09-30 | $6.27M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $6.57M 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $2.98M 10-K · filed 2018-05-10 | |
| 2017-12-31 | $7.02M 10-Q · filed 2019-02-07 | |
| 2017-09-30 | $9.77M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $12.12M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $14.12M 10-K · filed 2017-05-17 | |
| 2016-12-31 | $12.54M 10-Q · filed 2018-02-01 | |
| 2016-09-30 | $10.33M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $14.70M 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $16.51M 10-K · filed 2016-05-17 | |
| 2015-12-31 | $15.32M 10-Q · filed 2017-02-02 | |
| 2015-09-30 | $10.82M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $11.83M 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $16.98M 10-K · filed 2015-05-14 | |
| 2014-12-31 | $10.37M 10-Q · filed 2016-02-04 | |
| 2014-09-30 | $10.36M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $16.53M 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $7.39M 10-K · filed 2014-05-19 | |
| 2013-12-31 | $20.83M 10-Q · filed 2015-02-05 | |
| 2013-09-30 | $16.11M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $9.84M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $10.47M 10-K · filed 2013-05-17 | |
| 2012-12-31 | $11.33M 10-Q · filed 2014-02-07 | |
| 2012-09-30 | $16.60M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $13.88M 10-Q · filed 2013-08-01 | $13.88M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $5.13M 10-Q · filed 2013-02-07 | |
| 2011-09-30 | $2.13M 10-Q · filed 2012-11-07 | |
| 2011-06-30 | $7.88M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |